Detalhe da pesquisa
1.
Adverse effects in traditional and alternative toxicity tests.
Regul Toxicol Pharmacol
; 148: 105579, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309424
2.
OECD harmonised template 201: Structuring and reporting mechanistic information to foster the integration of new approach methodologies for hazard and risk assessment of chemicals.
Regul Toxicol Pharmacol
; 142: 105426, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277057
3.
A framework for establishing scientific confidence in new approach methodologies.
Arch Toxicol
; 96(11): 2865-2879, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987941
4.
Selecting a minimal set of androgen receptor assays for screening chemicals.
Regul Toxicol Pharmacol
; 117: 104764, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798611
5.
Development and Validation of a Computational Model for Androgen Receptor Activity.
Chem Res Toxicol
; 30(4): 946-964, 2017 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27933809
6.
Prediction of Estrogenic Bioactivity of Environmental Chemical Metabolites.
Chem Res Toxicol
; 29(9): 1410-27, 2016 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27509301
7.
Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.
Environ Sci Technol
; 49(14): 8804-14, 2015 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26066997
8.
Correction to Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.
Environ Sci Technol
; 51(16): 9415, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28767231
9.
Standardisation and international adoption of defined approaches for skin sensitisation.
Front Toxicol
; 4: 943152, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36032790
10.
Development of an Evidence-Based Risk Assessment Framework.
ALTEX
; 39(4): 667-693, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098377
11.
Characterisation and validation of an in vitro transactivation assay based on the 22Rv1/MMTV_GR-KO cell line to detect human androgen receptor agonists and antagonists.
Food Chem Toxicol
; 152: 112206, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887398
12.
Applying evidence-based methods to the development and use of adverse outcome pathways
ALTEX
; 38(2): 336-347, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837437
13.
OECD approaches and considerations for regulatory evaluation of endocrine disruptors.
Mol Cell Endocrinol
; 504: 110675, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31830512
14.
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification.
Nat Rev Endocrinol
; 16(1): 45-57, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719706
15.
The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification.
J Natl Cancer Inst
; 112(1): 30-37, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31498409
16.
When Are Adverse Outcome Pathways and Associated Assays "Fit for Purpose" for Regulatory Decision-Making and Management of Chemicals?
Integr Environ Assess Manag
; 15(4): 633-647, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30908812
17.
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.
Environ Health Perspect
; 127(9): 95001, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31487205
18.
Identification of candidate reference chemicals for in vitro steroidogenesis assays.
Toxicol In Vitro
; 47: 103-119, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146384
19.
Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.
Environ Health Perspect
; 125(9): 096001, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934726
20.
Identifying reference chemicals for thyroid bioactivity screening.
Reprod Toxicol
; 65: 402-413, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27589887